Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus.

John A Bonino1, Prateek Sharma

  • 1Division of Gastroenterology and Hepatology University of Kansas School of Medicine and Veterans Affairs Medical Center, Kansas City, Missouri 64128-2295, USA. psharma@kumc.edu

Current Opinion in Gastroenterology
|June 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of response to neoadjuvant chemotherapy in technically unresectable moderately advanced oral cavity cancers.

Journal of cancer research and therapeutics·2024
Same author

Assessment of quality of life in head and neck cancer patients visiting the Palliative Care outpatient department in a tertiary care oncology centre in India.

Indian journal of cancer·2024
Same author

Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2024
Same author

Endoscopic submucosal dissection and endoscopic mucosal resection for Barrett's-associated neoplasia: a systematic review and meta-analysis of the published literature.

Endoscopy·2024
Same author

Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases.

Pharmacological reports : PR·2024
Same author

Alteration of gastric microbiota in Helicobacter pylori - infected individuals suffering from gastroesophageal reflux disease, duodenal ulcer, and gastritis.

Indian journal of pathology & microbiology·2024
Same journal

Neuroendocrine tumors of the stomach and duodenum: evolving classification, endoscopic management, and surveillance.

Current opinion in gastroenterology·2026
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
See all related articles

Recent advances improve the identification and understanding of Barrett's esophagus, a condition increasing cancer risk. New insights into epidemiology, pathogenesis, and biomarkers aid in surveillance and treatment, benefiting patient outcomes.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Barrett's esophagus carries an increased risk of malignant transformation.
  • Understanding its epidemiology and pathogenesis is crucial for early detection and management.

Purpose of the Study:

  • To summarize recent advances in the identification, understanding, and management of Barrett's esophagus.
  • To highlight improvements in epidemiology, pathogenesis, surveillance, and treatment.

Main Methods:

  • Review of recent literature and studies on Barrett's esophagus.
  • Analysis of epidemiological data, molecular pathways, and biomarker identification.
  • Evaluation of surveillance protocols and treatment modalities.

Main Results:

Related Experiment Videos

  • Barrett's esophagus is increasingly recognized, linked to extra-esophageal reflux symptoms.
  • Acidic environments and MAPK pathways may contribute to COX-2 expression.
  • Familial predisposition exists; surveillance endoscopy shows survival benefits.
  • Endoscopic ablative therapy offers an alternative for high-grade dysplasia and early adenocarcinoma.

Conclusions:

  • Significant progress has been made in Barrett's esophagus research over the past year.
  • Advances in epidemiology, pathogenesis, surveillance, and treatment are vital for improved patient outcomes.